Somatic CDH1 pathogenic variants are associated with invasive lobular carcinoma (ILC), which shows a tenfold higher enrichment than infiltrating ductal carcinoma, underscoring the need for CDH1 genetic testing in women with ILC (Yadav et al. 2021). This evidence concerns the gene CDH1 and invasive lobular breast carcinoma.